GLP-1 receptor agonists are becoming a game changer in the treatment of obesity. However, using them without medical supervision is risky. We report on the potential of GLP-1 treatment.
new2026English
Health & FitnessHealthTechnologyAdviceFitnessMedicineDocumentary